HighTower Advisors’s Teladoc Health TDOC Stock Holding History

HighTower Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,500	Closed	-$475	–	3973
2024 Q2	$475	Buy	+2,500	New	+$30.5K	﹤0.01%	3595
2022 Q2	–	Sell	-2	Closed	-$1K	–	3525
2022 Q1	$1K	Buy	+2	New	+$144	﹤0.01%	3378
2021 Q3	–	Sell	-200	Closed	-$1K	–	3432
2021 Q2	$1K	Buy	+200	New	+$32.4K	﹤0.01%	3123
2021 Q1	–	Sell	-8	Closed	-$39K	–	3261
2020 Q4	$39K	Sell	8 -2,492	-100%	-$507K	﹤0.01%	2432
2020 Q3	$26K	Buy	+2,500	New	+$529K	﹤0.01%	2354
2019 Q2	–	Sell	-600	Closed	-$2K	–	2505
2019 Q1	$2K	Buy	600 +400	+200%	+$24.4K	﹤0.01%	2257
2018 Q4	$5K	Hold	200	–	–	﹤0.01%	2148
2018 Q3	$5K	Buy	+200	New	+$14.3K	﹤0.01%	2223

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

HighTower Advisors's TDOC Position: Q2 2026 in Review

HighTower Advisors increased its Teladoc Health (TDOC) stake by 21% in Q2 2026, buying an estimated $19.3K and bringing the position to 16,808 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

HighTower Advisors first reported a position in TDOC in Q2 2018 and has held it in 33 quarters since. The position peaked at $11.5M in Q4 2021. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

HighTower Advisors held 16,808 shares of Teladoc Health worth $143K as of Q2 2026.
HighTower Advisors bought 2,893 Teladoc Health shares in Q2 2026, an estimated $19.3K.
Teladoc Health made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3606 holding.
HighTower Advisors first reported a position in Teladoc Health in Q2 2018 and has held it in 33 quarters since.
HighTower Advisors's Teladoc Health position peaked at $11.5M in Q4 2021.
347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.